DeepGene

DeepGene (officially Beijing DeepGene Technology Co., Ltd.) is an artificial intelligence and bioinformatics company that provides advanced genomic analysis services for precision medicine. Founded in 2016 and headquartered in Beijing, the company specializes in multi-omics data integration, including genomics, transcriptomics, and proteomics, to support oncology research and clinical diagnostics. DeepGene's core technology is its proprietary "DeepGene" deep learning platform, which utilizes somatic mutation profiles and gene expression data to accurately classify cancer types and identify potential biomarkers. The company serves as a bioinformatics CRO, partnering with leading academic institutions and pharmaceutical firms to interpret complex sequencing data and accelerate the discovery of targeted therapies. DeepGene’s solutions aim to address challenges in genomic data sparsity and high dimensionality, facilitating more precise disease subtyping and clinical decision-making.